CERVIX CANCER
Clinical trials for CERVIX CANCER explained in plain language.
Never miss a new study
Get alerted when new CERVIX CANCER trials appear
Sign up with your email to follow new studies for CERVIX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cervical cancer
Disease control TerminatedThis study tested a combination of two drugs, toripalimab (an immunotherapy) and chidamide (a targeted therapy), in women with advanced cervical cancer that had returned or spread. The goal was to see if the combination was safe and could shrink tumors. Only 5 women took part bef…
Matched conditions: CERVIX CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Immune booster added to cervix cancer treatment – study halted early
Disease control TerminatedThis early-phase study aimed to see if adding the immunotherapy drug pembrolizumab to standard chemoradiation is safe for people with locally advanced cervix cancer. Only 1 person enrolled before the study was stopped. The goal was to find the safest dose and check for side effec…
Matched conditions: CERVIX CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Scans may predict radiotherapy success in cervical cancer
Knowledge-focused TerminatedThis study aimed to see if MRI and PET scans could predict whether radiotherapy is controlling cervical cancer. It included 9 patients with stage I to IIIB cervical cancer who were receiving chemoradiotherapy. The study was terminated early, so results are limited.
Matched conditions: CERVIX CANCER
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated May 17, 2026 06:50 UTC